Haleon sees higher sales in 2024 as FY profits come in flat

29th Feb 2024 07:23

(Sharecast News) - Consumer health firm Haleon on Thursday posted flat annual earnings and said it expected to grow revenue this year on higher demand.

The maker of Panadol pain relief, spun out of pharma giant GSK in 2022, posted pre-tax profits of £1.62bn for 2023, up 0.6%. It now expects revenue to rise 4% - 6% this year.

Revenue grew 4.1% to £11.3bn.

Reporting by Frank Prenesti for Sharecast.com

Top Risers

Share	Price	Change
Ukrproduct (UKR)	3.05	0%
Chaarat Gold (CGH)	3.90	0%
Fireangel (FA.)	5.75	0%
Synairgen (SNG)	7.00	0%
Image Scan Holdings (IGE)	1.60	0%

Top Fallers

Share	Price	Change
Eqtec (EQT)	1.10	0%
Gfinity (GFIN)	0.0252	0%
Strategic Minerals (SML)	0.17	0%
Uk Oil & Gas (UKOG)	0.027	0%
Apq Global (APQ)	6.50	0%

Top By Volume

Share	Price	Volume
Supply@me Cap (SYME)	0.01945	0
Mosman Oil Gas (MSMN)	0.022	0
Lloyds (LLOY)	55.52	0
Clontarf (CLON)	0.045	0
Beacon Energy. (BCE)	0.0575	0

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.